Conditions: Bronchiectasis
Keywords: bronchiectasis Phase II
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 38
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate if treatment with AZD9668 for 28 days is effective in treating Bronchiectasis (Brx) and if so how it compares to placebo (a substance which does not have any action).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: AZD9668 intervention 2: Placebo
Intervention descriptions: intervention 1: 2 x 30 mg, oral tablet, twice daily for 28 days intervention 2: 2 x Matched placebo, oral tablet, twice daily for 28 days

Protocol document: